(Q34510665)

2 August 2017

1 reference

title

A retrospective chart review of risperidone use in treatment-resistant children and adolescents with psychiatric disorders (English)

1 reference

2 August 2017

1 reference

1 reference

Jovan Simeon

1

1 reference

2 August 2017

Robert Milin

series ordinal

2

1 reference

2 August 2017

Selena Walker

series ordinal

3

1 reference

2 August 2017

publication date

1 February 2002

1 reference

Progress in Neuro-Psychopharmacology & Biological Psychiatry

2 August 2017

published in

1 reference

2 August 2017

volume

26

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

267-275

1 reference

Open-label treatment with risperidone of 26 psychiatrically-hospitalized children and adolescents with mixed diagnoses and aggressive behavior.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900264-0

7 January 2021

Effects of risperidone in tardive dyskinesia: an analysis of the Canadian multicenter risperidone study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900264-0

7 January 2021

Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900264-0

7 January 2021

A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. On behalf of the Risperidone Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900264-0

7 January 2021

A double-blind pilot study of risperidone in the treatment of conduct disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900264-0

7 January 2021

Risperidone treatment for juvenile bipolar disorder: a retrospective chart review

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900264-0

7 January 2021

A comparison of schizophrenic and autistic children.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900264-0

7 January 2021

A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900264-0

7 January 2021

Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900264-0

7 January 2021

Low incidence of persistent tardive dyskinesia in elderly patients with dementia treated with risperidone

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900264-0

7 January 2021

Prolactin levels and adverse events in patients treated with risperidone.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900264-0

7 January 2021

Risperidone implicated in the onset of tardive dyskinesia in a young woman

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900264-0

7 January 2021

Case study: risperidone-induced hepatotoxicity in pediatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900264-0

7 January 2021

Risperidone: clinical development: north American results

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900264-0

7 January 2021

Risperidone in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900264-0

7 January 2021

Improvement of Debilitating Tardive Dyskinesia with Risperidone

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900264-0

7 January 2021

Risperidone for young children with mood disorders and aggressive behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900264-0

7 January 2021

Risperidone-induced tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900264-0

7 January 2021

Risperidone-induced hepatotoxicity in children and adolescents? A chart review study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900264-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900264-0

1 reference

7 January 2021

Use of atypical neuroleptics in child and adolescent psychiatry.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900264-0

7 January 2021

10.1016/S0278-5846(01)00264-0

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mgp3yttgdzdznczkuwuwemvqme

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_mgp3yttgdzdznczkuwuwemvqme

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mgp3yttgdzdznczkuwuwemvqme

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/mgp3yttgdzdznczkuwuwemvqme

1 reference

30 July 2022